Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $282.1K | $494.4K | $1.5M | $1.0M | $4.2M | $822.2K | $3.0M | $6.5M |
| Cost of revenue | $52.0K | $90.4K | $139.7K | $88.8K | $145.1K | $850.8K | $1.9M | $3.7M |
| Gross profit | $230.2K | $404.0K | $1.3M | $948.5K | $4.0M | −$28.6K | $1.1M | $2.9M |
| Gross margin | 81.6% | 81.7% | 90.6% | 91.4% | 96.5% | -3.5% | 36.0% | 44.0% |
| R&D | $0 | $0 | $0 | $398.4K | $216.4K | $544.0K | $165.9K | $489.7K |
| Operating income | −$640.4K | −$2.6M | −$1.8M | −$5.5M | −$5.2M | −$10.6M | −$6.8M | −$8.1M |
| EBITDA | −$678.5K | −$2.6M | −$1.8M | −$5.5M | −$5.2M | −$10.8M | −$6.9M | −$7.1M |
| Net income | −$702.2K | −$3.1M | −$2.2M | −$8.3M | −$6.7M | −$10.9M | −$8.0M | −$9.1M |
| Net margin | -248.9% | -622.2% | -146.4% | -804.7% | -160.0% | -1324.8% | -266.0% | -139.3% |
| EPS (diluted) | -1.59 | -6.68 | -4.46 | -15.21 | -6.26 | -8.99 | -5.13 | -30.19 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $8M | $-0.98 | $-0.98–$-0.98 | 1 |
| 2027 | $8M | $-1.84 | $-1.84–$-1.84 | 1 |
| 2028 | $9M | $-1.67 | $-1.67–$-1.67 | 1 |
| 2029 | $10M | $-1.69 | $-1.69–$-1.69 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds NAYA.
No tracked institution reports a position in NAYA as of their last filing.
| Execution date | Ratio |
|---|---|
| 2025-03-18 | 1-for-12reverse |
No one on the platform has traded NAYA yet.
| $2M |
| — |
| NBSENeuBase Therapeutics, Inc. | $0.38 | -1.56% | $1M | — |
| ONCSQOncoSec Medical Incorporated | $0.00 | +0.00% | $596 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.